Home BeOne Medicines and Shanghai Pharma Announce Strategic Partnership to Accelerate Commercialization of Tarlatamab in China

BeOne Medicines and Shanghai Pharma Announce Strategic Partnership to Accelerate Commercialization of Tarlatamab in China

May 28, 2026 13:04 CST Updated 14:45
Shanghai Pharma

Modern Pharmaceutical Supply Chain Service Provider

BeOne

Developer of Molecular Targeted and Immune Anti-Tumor Drugs

MediTrust Health

Innovative Inclusive Health Medical Service and Security Platform